Last reviewed · How we verify
Zinc-l-carnosine — Competitive Intelligence Brief
marketed
Mucosal protectant / Gastroprotective agent
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Zinc-l-carnosine (Zinc-l-carnosine) — Fondazione IRCCS Policlinico San Matteo di Pavia. Zinc-l-carnosine forms a chelate complex that protects and promotes healing of the gastrointestinal mucosa by reducing oxidative stress and enhancing mucosal defense mechanisms.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Zinc-l-carnosine TARGET | Zinc-l-carnosine | Fondazione IRCCS Policlinico San Matteo di Pavia | marketed | Mucosal protectant / Gastroprotective agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Mucosal protectant / Gastroprotective agent class)
- Fondazione IRCCS Policlinico San Matteo di Pavia · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Zinc-l-carnosine CI watch — RSS
- Zinc-l-carnosine CI watch — Atom
- Zinc-l-carnosine CI watch — JSON
- Zinc-l-carnosine alone — RSS
- Whole Mucosal protectant / Gastroprotective agent class — RSS
Cite this brief
Drug Landscape (2026). Zinc-l-carnosine — Competitive Intelligence Brief. https://druglandscape.com/ci/zinc-l-carnosine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab